Abrupt visual loss during anti-vascular endothelial growth factor treatment for type 3 neovascularization
Journal Title: International Journal of Ophthalmology - Year 2019, Vol 12, Issue 3
Abstract
"AIM: To investigate the incidence of abrupt visual loss and its associated factors, during anti-vascular endothelial growth factor (VEGF) treatment for type 3 neovascularization. METHODS: This retrospective study included 137 eyes that were newly diagnosed with type 3 neovascularization. All eyes were treated with anti-VEGF therapy. Abrupt visual loss was defined as loss of 5 or more lines in best-corrected visual acuity (BCVA) in comparison to the previous visit. The incidence and timing of abrupt visual loss as well as the factors associated with it, were determined. In addition, the BCVA at the final follow-up was compared between the eyes with and those without abrupt visual loss. RESULTS: The mean follow-up period was 42.4±18.9mo after diagnosis, and abrupt visual loss was noted in 22 eyes (16.1%) at a mean of 19.6±13.9mo. Abrupt visual loss was found to be associated with subretinal hemorrhage in 11 eyes (50.0%), development of or increase in the height of pigment epithelial detachment with fluid in 8 eyes (36.4%), and tears in the retinal pigment epithelium in 3 eyes (13.6%). The logarithm of minimum angle of resolution (logMAR) mean BCVA at the final follow-up was 2.07±0.67 (Snellen equivalents: 20/2349) and 1.00±0.55 (20/200) in eyes with and without abrupt visual loss, respectively. BCVA was significantly worse in the eyes with abrupt visual loss (P<0.001). CONCLUSION: Abrupt visual loss is noted in 16.1% of patients with type 3 neovascularization and is associated with poor visual outcome. Additional studies are needed to determine how abrupt visual loss can be prevented."
Authors and Affiliations
Jae Hui Kim
Keywords
Related Articles
- EP ID EP591506
- DOI 10.18240/ijo.2019.03.20
- Views 52
- Downloads 0
Sectoral changes of the peripapillary choroidal thickness in patients with unilateral branch retinal vein occlusion
"AIM: To investigate sectoral changes in the mean peripapillary choroidal thickness (PCT) in patients with unilateral branch retinal vein occlusion (BRVO). METHODS: This retrospective, interventional study included 41 pa...
Foveal thickness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema
"AIM: To report foveal thickness reduction in eyes with resolution of macular edema and recovery of a foveal depression after one-year of anti-vascular endothelial growth factor (anti-VEGF) therapy for center-involving d...
Down regulation of UCP2 expression in retinal pigment epithelium cells under oxidative stress: an in vitro study
"AIM: To evaluate the expression of uncoupling protein 2 (UCP2) in a retinal pigment epithelium cell line (ARPE-19), under oxidative stress (OS). METHODS: ARPE-19 cells were divided into groups treated with various conce...
Optic disc and peripapillary changes by optic coherence tomography in high myopia
Myopia, a worldwide condition, is a multifactorial disease resulting in many ocular complications. Early onset of myopia has a great tendency to develop high myopia and pathological myopia later in life. The pathophysiol...
Comparison of corneal biomechanics in Sjögren’s syndrome and non-Sjögren’s syndrome dry eyes by Scheimpflug based device
"AIM: To compare the corneal biomechanics of Sjögren’s syndrome (SS) and non-SS dry eyes with Corneal Visualization Scheimpflug Technology (CorVis ST). METHODS: Corneal biomechanics and tear film parameters, namely the S...